Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Therapeutic evaluation of polyamine analogue drug candidates against Enterocytozoon bieneusi in a SCID mouse model.

Feng X, Reddy VK, Mayanja-Kizza H, Weiss LM, Marton LJ, Tzipori S.

Antimicrob Agents Chemother. 2009 Jun;53(6):2417-23. doi: 10.1128/AAC.01113-08. Epub 2009 Mar 16.

2.

Microsporidiosis in solid organ transplant recipients: two Enterocytozoon bieneusi cases and review.

Lanternier F, Boutboul D, Menotti J, Chandesris MO, Sarfati C, Mamzer Bruneel MF, Calmus Y, Mechaï F, Viard JP, Lecuit M, Bougnoux ME, Lortholary O.

Transpl Infect Dis. 2009 Feb;11(1):83-8. doi: 10.1111/j.1399-3062.2008.00347.x. Epub 2008 Sep 18. Review.

PMID:
18803616
3.

Successful treatment with fumagillin of the first pediatric case of digestive microsporidiosis in a liver-kidney transplant.

Desoubeaux G, Maakaroun-Vermesse Z, Lier C, Bailly E, Morio F, Labarthe F, Bernard L, Chandenier J.

Transpl Infect Dis. 2013 Dec;15(6):E250-9. doi: 10.1111/tid.12158. Epub 2013 Oct 23.

PMID:
24298986
4.

Potential efficacy of fumagillin in intestinal microsporidiosis due to Enterocytozoon bieneusi in patients with HIV infection: results of a drug screening study. The French Microsporidiosis Study Group.

Molina JM, Goguel J, Sarfati C, Chastang C, Desportes-Livage I, Michiels JF, Maslo C, Katlama C, Cotte L, Leport C, Raffi F, Derouin F, Modaï J.

AIDS. 1997 Nov;11(13):1603-10.

PMID:
9365765
5.

Intestinal microsporidiosis due to Enterocytozoon bieneusi in a pediatric kidney transplant recipient successfully treated with fumagillin.

Godron A, Accoceberry I, Couret A, Llanas B, Harambat J.

Transplantation. 2013 Oct 27;96(8):e66-7. doi: 10.1097/TP.0b013e3182a902e7. No abstract available.

PMID:
24132119
6.

Fumagillin for treatment of intestinal microsporidiosis in renal transplant recipients.

Champion L, Durrbach A, Lang P, Delahousse M, Chauvet C, Sarfati C, Glotz D, Molina JM.

Am J Transplant. 2010 Aug;10(8):1925-30. doi: 10.1111/j.1600-6143.2010.03166.x. Epub 2010 Jul 15.

7.

Fumagillin-induced aseptic meningoencephalitis in a kidney transplant recipient with microsporidiosis.

Audemard A, Le Bellec ML, Carluer L, Dargère S, Verdon R, Castrale C, Lobbedez T, Hurault de Ligny B.

Transpl Infect Dis. 2012 Dec;14(6):E147-9. doi: 10.1111/tid.12010. Epub 2012 Oct 2.

PMID:
23025483
8.

Trial of oral fumagillin for the treatment of intestinal microsporidiosis in patients with HIV infection. ANRS 054 Study Group. Agence Nationale de Recherche sur le SIDA.

Molina JM, Goguel J, Sarfati C, Michiels JF, Desportes-Livage I, Balkan S, Chastang C, Cotte L, Maslo C, Struxiano A, Derouin F, Decazes JM.

AIDS. 2000 Jul 7;14(10):1341-8.

PMID:
10930148
9.

Serial propagation of the microsporidian Enterocytozoon bieneusi of human origin in immunocompromised rodents.

Feng X, Akiyoshi DE, Sheoran A, Singh I, Hanawalt J, Zhang Q, Widmer G, Tzipori S.

Infect Immun. 2006 Aug;74(8):4424-9.

10.

Fumagillin treatment of intestinal microsporidiosis.

Molina JM, Tourneur M, Sarfati C, Chevret S, de Gouvello A, Gobert JG, Balkan S, Derouin F; Agence Nationale de Recherches sur le SIDA 090 Study Group.

N Engl J Med. 2002 Jun 20;346(25):1963-9.

11.

Microsporidiosis: an emerging and opportunistic infection in humans and animals.

Didier ES.

Acta Trop. 2005 Apr;94(1):61-76. Review.

PMID:
15777637
12.
14.

Unusual pulmonary Enterocytozoon bieneusi microsporidiosis in an AIDS patient: case report and review.

Sodqi M, Brazille P, Gonzalez-Canali G, Cornet M, Piketty C, Weiss L.

Scand J Infect Dis. 2004;36(3):230-1. Review.

PMID:
15119373
15.

Monoclonal antibodies against Enterocytozoon bieneusi of human origin.

Sheoran AS, Feng X, Singh I, Chapman-Bonofiglio S, Kitaka S, Hanawalt J, Nunnari J, Mansfield K, Tumwine JK, Tzipori S.

Clin Diagn Lab Immunol. 2005 Sep;12(9):1109-13.

16.

Fumagillin for intestinal microsporidiosis.

Carr A, Cooper DA.

N Engl J Med. 2002 Oct 24;347(17):1381; author reply 1381. No abstract available.

PMID:
12397205
17.

Quantitative evaluation of Enterocytozoon bieneusi infection in simian immunodeficiency virus-infected rhesus monkeys.

Sestak K, Aye PP, Buckholt M, Mansfield KG, Lackner AA, Tzipori S.

J Med Primatol. 2003 Apr;32(2):74-81.

PMID:
12823629
18.

One-step purification of Enterocytozoon bieneusi spores from human stools by immunoaffinity expanded-bed adsorption.

Accoceberry I, Thellier M, Datry A, Desportes-Livage I, Biligui S, Danis M, Santarelli X.

J Clin Microbiol. 2001 May;39(5):1947-51.

19.

Purification of Enterocytozoon bieneusi from stools and production of specific antibodies.

Sheoran AS, Feng X, Kitaka S, Green L, Pearson C, Didier ES, Chapman S, Tumwine JK, Tzipori S.

J Clin Microbiol. 2005 Jan;43(1):387-92.

20.

Use of furazolidone for the treatment of microsporidiosis due to Enterocytozoon bieneusi in patients with AIDS.

Dionisio D, Sterrantino G, Meli M, Trotta M, Milo D, Leoncini F.

Recenti Prog Med. 1995 Oct;86(10):394-7.

PMID:
7501904

Supplemental Content

Support Center